Vital Images Inc. announced the FDA has granted 510(k) clearance for 3D viewing through the VitreaView universal viewer.
Vital Images Inc., a Toshiba Medical Systems Group company, has received FDA 510(k) clearance for 3D viewing through the VitreaView universal viewer, the company announced.
The advanced visualization and analysis company introduced VitreaView in June 2011. The viewer is used as a communication tool for DICOM and non-DICOM medical images through a standardized viewer, so clinicians can access the images through various systems.
“Now with 3D and tablet capabilities available via VitreaView, our customers, particularly referring physicians and clinicians, have more functionality and easier access to the tools they need,” Erkan Akyuz, president and CEO of Vital Images, said in a statement. “Also, with access to images through the EMR as part of the Stage 2 Meaningful Use criteria, VitreaView integrated with a certified EMR enables the ability to meet this objective, with a toolset and infrastructure that also meets the needs of clinical users and IT administrators.”
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.